Review of C2026: Grand Challenges for Predictive Modeling in Drug Discovery
In this blog post I’ll be taking a look at C2026 (Grand Challenges for Predictive Modeling in Small Molecule Drug Discovery) which has bee...
Read the full articleYou might also wanna read
Reflections on 2024 Bio-ML Predictions: Generative Chemistry and Molecular Dynamics Challenges
6.6k words, 30 minutes reading time
owlposting.com·6mo ago
STAT+: Drug metabolism AI competition results show that bigger may not always be better
The results of a recent AI competition show that better data trumps bigger models when it comes to predicting properties of drug candidates.
How LLMs Are Transforming Preclinical Drug Discovery Data Access
AI helping pharmaceutical researchers query decades of information buried in PDF reports
How LLMs Are Transforming Preclinical Drug Discovery Data Access
AI helping pharmaceutical researchers query decades of information buried in PDF reports
How LLMs Are Transforming Preclinical Drug Discovery Data Access
AI helping pharmaceutical researchers query decades of information buried in PDF reports
Generic ML Modeling vs. Molecular Modeling: Which Does Your Lab Need?
Compare generic machine learning and molecular modeling to discover which approach best fits your chemical R&D workflows and innovation goal
Rethinking Drug Interactions: A Focal Shift in AI Prediction
A new approach in graph neural networks significantly boosts drug interaction predictions. Focusing on tougher cases, the ClinicalFocal loss
Why Retrosynthesis Models Are Winning Over LLMs in Drug Discovery
Retrosynthesis models outperform large language models (LLMs) in drug synthesis planning. The URSA framework highlights this gap in precisio
Comments
Sign in to join the conversation.
No comments yet. Be the first.